REGEND007 Cell Therapy

· Regend Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGEND007 Cell Therapy, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy [EARLY_Phase 1]